Friday September 24, 2021 - 22:25 to 23:30
Henk-Jan Schuurman was trained in Chemistry, and received his PhD in 1977 from Utrecht University, the Netherlands. After a university position in clinical and experimental Immunology/Internal Medicine/Pathology, he joined pharmaceutical industry in 1992: he then served pharma/biotech companies in Switzerland, United Kingdom and USA in various positions at the interface between research and clinical development, in the area of biomedical science with emphasis on (xeno)transplantation. In 2006 he was appointed Professor of Surgery to support preclinical studies at the University of Minnesota, USA. The focus of his work during these decades in his career was on translational research, and this gradually included also business and regulatory affairs. Dr Schuurman has widely published in the field of (medical) immunology, including transplantation biology, immunodeficiency, immunopathology and immunotoxicology, in all these areas with respect to translational medicine and experimental animal modeling. Between 2006 and 2020 he was Associate Editor of the journal ‘Xenotransplantation’. In 2010 Dr Schuurman founded Schubiomed Consultancy, providing consultancy in the biomedical sector, in particular transplantation and xenotransplantation, with focus on advanced nonclinical research in preparation for first-in-man trials, including regulatory aspects and animal modeling (translational value). Henk-Jan brings a broad worldwide expertise in regulatory affairs of xenotransplantation addressing the various approaches with respect to regulation of cells, tissues an organs of xenogeneic origin.
Key publications during the last years: